Edgewise Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Edgewise Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -26.7 %, a 16.8% decline year-over-year.
  • Edgewise Therapeutics, Inc. annual Return On Assets for 2023 was -30.2 %, a 42.1% decline from 2022.
  • Edgewise Therapeutics, Inc. annual Return On Assets for 2022 was -21.2 %, a 48.1% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -26.7 -3.83 -16.8% Apr 1, 2024 Jun 30, 2024
Q1 2024 -27.6 -5.07 -22.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -30.2 -8.93 -42.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -26.4 -5.96 -29.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -22.9 -2.54 -12.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -22.5 -4.97 -28.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.2 -6.89 -48.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -20.4 -6.42 -45.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -20.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -17.5 Jan 1, 2022 Mar 31, 2022
Q4 2021 -14.3 Oct 1, 2021 Dec 31, 2021
Q3 2021 -14 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.